title: Malignant myelomatous pleural effusion with good response to combination chemotherapy.
abstract: Malignant pleural effusion in myeloma is a rare terminal event with 91 cases reported so far. Majority of the patients survive less than 4 months. We are presenting a short series of four such cases, who had a good clinical response to combination chemotherapy.
authors.affiliation: Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
authors.forename: V S S
authors.initials: VS
authors.lastname: Attili
authors.forename: V P
authors.initials: VP
authors.lastname: Singh
authors.forename: S
authors.initials: S
authors.lastname: Sundar
authors.forename: H
authors.initials: H
authors.lastname: Mehta
authors.forename: M L
authors.initials: ML
authors.lastname: Negi
authors.forename: A
authors.initials: A
authors.lastname: Gogia
authors.forename: S H K
authors.initials: SH
authors.lastname: Raju
authors.forename: M
authors.initials: M
authors.lastname: Rai
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D016066:Pleural Effusion, Malignant / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin